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outlook remains correspondingly improved. The fall in diastolic pressure remained greatest in patients in whom it was dangerously high, over 100 mmHg, before operation, and this must surely be a good prognostic sign.
There have been no operative or early postoperative deaths in my series of 40 cases, so it seems reasonable to claim that the operation can be carried out with little risk to life.
There has been very little morbidity in my series. One patient required post-operative transfusion for hemorrhage and one developed a chylothorax which necessitated re-thoracotomy. Apart from these two cases there has been no significant morbidity and I have not encountered the complications mentioned by Owens & Swan (1963) , such as serious hemorrhage, cardiac arrest, mesenteric arteritis, paraplegia, and postthoracotomy pain. I have not found any need for hypotensive drugs (Sellors & Hobsley 1963) or for hypothermia (Owens & Swan 1963) . Points which may account for the relative freedom from complications are: (1) An intercostal approach is made without rib resection. (2) Intercostal arteries are rarely ligated and then not more than two. (3) Operations seldom take more than ninety minutes total time and the aorta is seldom clamped for more than twenty minutes.
The operations in my series have been either complete resection and anastomosis (28 cases) or excision of a crescent on the posterolateral aspect of the coarctation and anastomosis (12 cases), leaving the ligamentum arteriosum intact (Walker & Haxton 1954) . There has been no significant difference, in either the early or the later results, between these two procedures.
Summary
Sixteen cases have been reviewed eight to twenty years after resection of aortic coarctations. Apart from one death after three years, all were healthy with no late complications. Blood pressures remained substantially lowered in all but 2 and it is thought that the prognosis remains correspondingly improved. In my series of 40 cases there have been no operative or early post-operative deaths, and very little morbidity. The ultimate object of the work to be described is to elucidate the mechanism of sweat elaboration with special reference to sodium excretion and also, if possible, to define the sodium excretion defect in the sweat gland of the fibrocystic individual which results in sodium concentrations of 70-130 mEq/l in the sweat of these individuals compared with values of 10-60 mEq/l in normal children. We decided to investigate the problem in vivo by introducing drugs and ions iontophoretically into the skins of fibrocystic and normal children in an attempt either to repair the biochemical abnormality in a fibrocystic individual or to simulate it in a normal subject. If we succeeded in this aim, we felt that we might gain an insight into the natural lesion.
The eccrine sweat gland consists of two main portions: a secretory coil and a duct. The process of sweat formation commences in the secretory coil. Although the epithelium consists of a single layer of cells, they are of two distinct types: small dark cells, containing mucopolysaccharides, and large 'clear cells' containing variable amounts of glycogen. The clear cells probably secrete the aqueous sweat and the dark cells produce a mucinous material. The primary process of sweat formation is widely believed to be the passage of sodium ions into the lumen of the secretory coil. This is followed by the movement of water and other solutes to maintain ionic and osmotic equilibrium. Unless one postulates active transport of water, it is difficult to see how the fluid so formed could be hypotonic. Recently evidence has been accumulating that the coil fluid has the same sodium concentration as extracellular fluid. However, the Na concentration of sweat secreted on to the skin surface is hypotonic. It follows that some Na must be reabsorbed in the duct and that the ductal membrane cannot be freely permeable to water.
In our studies the Na concentration of sweat was the criterion by which the effects of drugs and ions were to be assessed. It was therefore necessary to compare the secretion from drug-treated glands with that from control glands. Here one problem facing the investigator is reproducibility. ability of the Na concentration in any one subject tested at different times. Each point represents one five-minute sweat sample. Clearly, this lack of reproducibility of the Na concentration renders any assessment of a drug effect impossible. There are a number of factors which influence the concentration of Na in sweat, e.g. the dietary state of the individual, his aldosterone secretion rate, and above all the rate of sweat secretion. To obviate the influences of any change in environment, diet, hormonal balance or other, unsuspected, physiological variants, we performed several sweat tests almost simultaneously on one subject. Fig I  (right) shows that the scatter of individual Na concentrations found in such an experiment is much reduced. The correlation between Na concentration and sweating rate is now apparent. The K concentration, on the other hand, is hardly affected by the sweating rate.
We have investigated the effects of a number of different drugs and ions. The most interesting observations so far have been made with calcium. We administered Ca by iontophoresis from a solution of CaCl2. The sweat glands in the test area were then stimulated with pilocarpine, also by iontophoresis, after which sweat was collected for four consecutive five-minute periods. A control experiment was performed without Ca within fifteen minutes of the test. The procedure was identical in all children. In 25 out of 42 nonfibrocystic children the Na concentration of the sweat from the calcium site was raised when compared with that from the control area. An example of this response may be seen in Fig 2. The Na concentration is raised in each of the 5 samples. We do not regard the Ca as having had a positive effect unless at least 3 of the 4 or 4 of the 5 (Note: K has been shown to have no effect on the Na concentration)
specimens collected during a test show a raised Na concentration.
In the fibrocystic group, 25 children in all, 21 showed no increase in sweat Na concentration. An increase was apparent in the remaining 4 of this group. A typical example of a test on a fibrocystic child is presented in Fig 3. Clearly, the response to Ca is much more marked in the control group than in the fibrocystic group. Statistically the difference is highly significant (0-01 >P>0-001).
One may speculate on possible mechanisms by which Ca raises the Na concentration of sweat in control children. Such an effect must be the result either of increased transfer of Na into the lumen of the secretory coil or, more likely, of interference with reabsorption of Na in the duct. It is widely believed that Na, K-activated adenosinetriphosphatase is implicated in the transport of both these ions. Ca is known to inhibit this ATPase (Epstein & Whittam 1966) and has, in fact, been observed to decrease Na transport across the isolated frog skin. Thus, a partial inhibition of ATPase in the sweat duct by Ca could account for the observed effect of the ion on the Na concentration. That it does not invariably do so in normal subjects is not really surprising. After all, we do not know how much Ca is transported into the skin or how much reaches the site of its inhibitory activity. This is one of the snags of iontophoresis as a mode of administration of an ion: even if we control accurately the current density, we cannot be certain that all the current is carried by Ca ions. Another snag is that the dose of ion that can be administered is limited by the pain experienced at certain current densities. We find that 4 mA/9cm2 is about as much as one can stand in reasonable discomfort.
It is interesting to note that abnormally high Ca levels have been reported in the salivary (Chernick & Barbero 1963) and pulmonary secretions (Potter et al. 1963 ) and in duodenal fluid (Kopito & Shwachman 1964 ) of fibrocystic patients, though not in sweat (di Sant' Agnese 1967). We think that possibly a differentiation between ionic and nonionic Ca may be important here.
Thus, the substantial failure of fibrocystic subjects to respond to Ca in the manner seen in controls could be due to an abnormal ionic Ca Alternatively the reabsorption of sodium occurs by a process other than the suggested Na, K-ATPase mechanism susceptible to calcium ions.
There are, of course, other ways in which Ca ions might be exerting an effect on Na transport: Ca inhibits some glycolytic enzymes (Bygrave 1966) and so could reduce the energy supply to the ductal cell on which active transport depends;
Ca ions might combine with some glycoprotein in the sweat duct, thus blocking re-absorption; or they might modify the action of cholinergic agents, as they are known to do in the salivary glands (Douglas & Poisner 1963) and in the pancreas (Hokin 1966) .
It was with this hormonal involvement in mind that we looked at another phenomenon which has been observed (and ignored) by several investigators. The first sample of sweat collected in the course of an experiment has a higher Na concentration than would be expected from its secretion rate, compared with subsequent samples. Fig 4 shows this effect in 2 normal adults. On the left it can be seen that although the secretion rate rises slightly in the second 5-minute period, the Na concentration falls markedly in the same period, while the K concentration is substantially unchanged. From the tenth to the fortieth minute both sweating rate and Na concentration decline steadily. In the experiment illustrated on the right we collected an extra specimen of sweat after only 2+ minutes and again at five and ten minutes and so on. The sweating rate rises rapidly during the second 2i minute period and a little less so during the next five minutes. The Na concentration indeed shows a rise concurrently with the rapid initial increase in sweating rate, but this is again followed by a substantial fall while the sweating rate is still rising. Thus at 2+ and at 5 minutes the maximum (volume) response to Mecholyl has not been reached, yet the Na concentration is already falling. Fig 5 shows 2 examples of a similar observation in normal children: on the left, a steep increase in sweating rate is accompanied by a very moderate increase in Na concentration; on the right, a rise in sweating rate is concurrent with a fall in Na concentration.
Our first thought was that this was an artifact, due to contamination with Na or evaporation of water. Later, we wondered whether a small amount of sweat from a previous episode of sweating might remain in the sweat duct and be concentrated there by loss of water, although this (SR) and Na concentration in the course of a single sweat test. Two healthy children was contraindicated by the finding of a high Na concentration even in the second 21-minute specimen, i.e. after any residual, concentrated sweat must have been washed out by the first specimen.
We have observed this 'first sample phenomenon', a Na concentration up to 30 % higher than in subsequent samples, in 31 out of 43 control children. In contrast, this observation was made in only 3 out of 31 fibrocystic children. This highly significant difference (P < 0001) between the control and fibrocystic groups rules out the possibility of accidental contamination, loss of water, or interference by residual sweat.
We are left with the speculation that the 'first sample phenomenon' may be due to a delay in Na reabsorption, betraying a time lag between the onset of fluid production by the coil and the attainment of efficient reabsorption of Na by the duct. There is no detectable time lag in the fibrocystic subject, but then there is very much less Na reabsorbed anyway. Could it be that the stimulus to increased Na reabsorption is lacking in cystic fibrosis, or are we dealing with a failure of the duct to respond?
It is fashionable and indeed prudent to include abnormal glycoproteins in any hypothesis on the etiology and pathogenesis of cystic fibrosis.
The suggestion by Ellis (1965) that glycoprotein might play a role in transport may be the basis of such a hypothesis embracing our findings so far: glycoprotein secretion from the small dark cells of the coil lags behind the production of precursor fluid, and maximum Na reabsorption is thus delayed. The abnormal glycoprotein of cystic fibrosis is a poor Na carrier and hence reabsorption of the ion is much reduced. Calcium there-fore has no effect on the performance of the fibrocystic sweat gland. Alternatively, Ca might interact with the carrier glycoprotein and so interfere with Na transport, both in the calcium-treated control and in the untreated fibrocystic.
We hope that the results reported here together with those from further investigations which are being planned will bring about a better understanding of the process of normal sweat secretion and of the biochemical lesion in cystic fibrosis.
The Spontaneous Disappearance of Interatrial Shunts in Infancy by G H Watson MB MRCP and J F Dark MB FRCS (Royal Manchester Children's Hospital. Pendlebury, Manchester) It is now well known that ventricular septal defects (VSD) and patent ductus arteriosus (PDA) may close spontaneously, but less attention has been paid to the possibility that atrial septal defects (ASD) may close. In the following cases a left-to-right atrial shunt was present in infancy but later ceased.
Case 1
This infant failed to thrive; cardiac investigations at the age of 9 months showed an ASD and a PDA, marked pulmonary hypertension, equal left-to-right atrial and ductal shunts, and a pulmonary blood flow equal to three times the systemic flow (P/S flow ratio = 3). On angiography a left ventricular injection showed no early intracardiac shunt, but a left atrial injectoin showed a large shunt into the right atrium. The ductus was ligated soon afterwards. At the age of 4 years the child was well; catheterization showed
